FDA to approve shared system REMS for TIRF products
The U.S. Food and Drug Administration today approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for the transmucosal immediate-release fentanyl (TIRF) products.
-
Subscribe
Subscribe via the RSS feed